New episode is up, but only for subs rn.
Niklas Anzinger has spent the last few years building a biotech hub inside Próspera. In this conversation he makes the case that the FDA's monopoly on who gets to try what medicine is costing lives, and that the cracks are finally appearing.
Dog cancer vaccines built at home for $3,000 with AlphaFold.
Sid Sijbrandij going founder mode on his own bone cancer.
China eating 30% of global pharma licensing deals in a decade.
Montana and New Hampshire quietly cracking open the Right to Try framework.
And why Próspera's insurance-based regulatory model might be the most important governance innovation nobody's talking about.
Early access on @Fountain now. General release Friday at 6.15am GMT.
https://fountain.fm/episode/d0sQp6idoayM1GrrVXHx
Timothy / Timothy Allen
npub1gc…vqjg0
2026-06-04 09:03:42 UTC
Author Public Key
npub1gcf9ltaeu42f4tr20z3avkas04dezlx3jaudqsuu87gvmh686xasrvqjg0Published at
2026-06-04 09:03:42 UTCEvent JSON
{
"id": "83fa4c6613e245f6f36e486a9c0aded72011ac0fc6ed46f8bbcfc6cf7e8d9b98",
"pubkey": "46125fafb9e5549aac6a78a3d65bb07d5b917cd19778d0439c3f90cddf47d1bb",
"created_at": 1780563822,
"kind": 1,
"tags": [
[
"r",
"wss://nostr.mom/",
"write"
],
[
"r",
"wss://nostr.oxtr.dev/",
"write"
],
[
"r",
"wss://nos.lol/"
],
[
"r",
"wss://purplepag.es/",
"write"
],
[
"r",
"wss://nostr.azzamo.net/",
"write"
],
[
"r",
"wss://eden.nostr.land/",
"write"
],
[
"r",
"wss://relay.damus.io/"
],
[
"r",
"wss://relay.mostr.pub/",
"write"
],
[
"r",
"wss://relay.primal.net/",
"write"
],
[
"r",
"wss://relay.snort.social/"
],
[
"r",
"wss://relay.fountain.fm/",
"read"
],
[
"client",
"Primal Web"
]
],
"content": "New episode is up, but only for subs rn.\n\nNiklas Anzinger has spent the last few years building a biotech hub inside Próspera. In this conversation he makes the case that the FDA's monopoly on who gets to try what medicine is costing lives, and that the cracks are finally appearing.\n\nDog cancer vaccines built at home for $3,000 with AlphaFold. \nSid Sijbrandij going founder mode on his own bone cancer. \nChina eating 30% of global pharma licensing deals in a decade. \nMontana and New Hampshire quietly cracking open the Right to Try framework. \nAnd why Próspera's insurance-based regulatory model might be the most important governance innovation nobody's talking about.\n\nEarly access on @Fountain now. General release Friday at 6.15am GMT.\n\nhttps://fountain.fm/episode/d0sQp6idoayM1GrrVXHx",
"sig": "fd2458fc09fbfc4458d4ee15c1f8fa93f07ba46b92d0c26e285b316a598e176aeac8e695f64ad02ad187a04ff6cbfc7b80c2201a6ccfe44f9f24a4145f63f1a5"
}